# An Integrated Artificial Intelligence Approach for Predicting Analgesic Time Based on Nalbuphine Versus Morphine as Adjuvants to Bupivacaine in Ultrasound-Guided Supraclavicular Block

> **NCT07008443** · PHASE4 · COMPLETED · sponsor: **Alzahraa Ahmed Abbas** · enrollment: 60 (actual)

## Conditions studied

- Regional Anesthesia Block
- Upper Limb Surgery

## Interventions

- **DRUG:** Bupivacaine + saline
- **DRUG:** Bupivacaine + nalbuphine
- **DRUG:** Bupivacaine + morphine

## Key facts

- **NCT ID:** NCT07008443
- **Lead sponsor:** Alzahraa Ahmed Abbas
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07008443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07008443, "An Integrated Artificial Intelligence Approach for Predicting Analgesic Time Based on Nalbuphine Versus Morphine as Adjuvants to Bupivacaine in Ultrasound-Guided Supraclavicular Block". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07008443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*